Fox Chase Cancer Center, Genome Profiling Partner on Immune Epigenetic Research
GenPro will use its EpiMarker machine-learning platform to identify a network of genomic DNA methylation sites in patients' circulating immune cells that may be predictive of drug response.
DoD Awards Fox Chase Researcher $673K to Develop Lung Cancer Test
Martin Edelman will investigate whether cancer associated macrophage-like cells can determine whether small or indeterminate lung nodules are cancerous or benign.
Natera Partners With Fox Chase to Evaluate ctDNA Cancer Assay
The Signatera research-use-only assay monitors cancer treatment and assesses minimal residual disease, and is customized for individual patients.